Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.

Jin, Yabin; Deng, Jianzhong; Luo, Bing; Zhong, Yubo; Yu, Si

Jin, Yabin; Deng, Jianzhong; Luo, Bing; Zhong, Yubo; Yu, Si.

Afiliación

Jin Y; Institute of Clinical Research, The First People's Hospital of Foshan, Foshan, China.
Deng J; Department of Anorectal Surgery, The First People's Hospital of Foshan, Foshan, China.
Luo B; Department of Gastrointestinal Surgery, The Second People's Hospital of Foshan, Foshan, China.
Zhong Y; Department of Gastrointestinal Surgery, The Second People's Hospital of Foshan, Foshan, China.
Yu S; Department of Gastrointestinal Surgery, The Second People's Hospital of Foshan, Foshan, China.

Front Endocrinol (Lausanne) ; 13: 963382, 2022.

Article en En | MEDLINE | ID: mdl-36440228

Asunto(s)

Neoplasias del Colon; Galectina 4; Humanos; Pronóstico; Neoplasias del Colon/genética; Neoplasias del Colon/terapia; Inmunoterapia; Área Bajo la Curva

Palabras clave

biomarker; colon cancer; immune cells; prognostic model; tumor microenvironment (TME)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Colon / Galectina 4 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google